Eric Weisblum
CEO at Silo Pharma, Inc. (SILO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$20K
Total bought / sold$8K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 16SEC | SILOSilo Pharma, Inc. | Buy | 2,500214,432 held (+1%) | $0.41 | $1K | +258.5% |
| Dec 16SEC | SILOSilo Pharma, Inc. | Buy | 2,500216,932 held (+1%) | $0.42 | $1K | +250.0% |
| Nov 21SEC | SILOSilo Pharma, Inc. | Buy | 1,000210,932 held (+0%) | $0.37 | $370 | +297.3% |
| Nov 21SEC | SILOSilo Pharma, Inc. | Buy | 1,000211,932 held (+0%) | $0.37 | $370 | +297.3% |
| Nov 20SEC | SILOSilo Pharma, Inc. | Buy | 7,500205,432 held (+4%) | $0.40 | $3K | +267.5% |
| Nov 20SEC | SILOSilo Pharma, Inc. | Buy | 4,500209,932 held (+2%) | $0.41 | $2K | +258.5% |
- Buy
CEO Eric Weisblum bought $3K of SILO at $0.40 — first open-market purchase in our records.